Good Evening Market Enthusiast,

The small-cap space is full of hope-and-wait stories.

This one? It’s already done waiting.

A final-stage merger is closing. A fresh Nasdaq ticker is about to appear. 

And a new dual-engine biotech with clinical activity already underway is stepping into the light.

The setup includes:
 

• A clean structure, zero debt
• Small-molecule precision + cell therapy regeneration
• 100+ patents, global reach
• $6M already in the bank, $25M facility lined up
• Billion-dollar CNS and diabetes targets
• Clinical trials already enrolling in ALS
   

This isn’t about “watching for news” — the transformation goes live on October 30. And the market will see it October 31 when the ticker flips.

Execution is on a calendar now.

So is the window for early eyes.

⏰ The full breakdown hits at 8AM EST tomorrow.

You’ve got one shot to be ahead of it.

To your success,

Max Masters

Co-founder, Market Tips Newsletter

Paid Promotion. Please read Momentum Media LLC’s complete disclaimer at https://markettips.net/disclaimer/ which includes important information. Emojis, graphics and/or images used herein have no specific or implied meaning, and are used for artistic purposes only. Nothing contained herein is fina.ncial advice. Momentum Media LLC is not an analyst, st.o.ck broker, fina.ncial adviser or st.o.ck picker nor is it qualified to act in the capacity of any of the foregoing. Information herein is a paid advertisement and should not be relied upon as accurate or complete.